Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Aug 31, 2025 | (Q4)Aug 31, 2025 | (Q3)May 31, 2025 | (Q2)Feb 28, 2025 | (Q1)Nov 30, 2024 | (FY)Aug 31, 2024 | (Q4)Aug 31, 2024 | (Q3)May 31, 2024 | (Q2)Feb 29, 2024 | (Q1)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -26.04%89.37M | -53.35%20.56M | 59.68%22.33M | -42.36%25.89M | -36.10%20.09M | 169.69%120.84M | 246.65%44.08M | 5.39%13.99M | 391.54%44.92M | 224.75%31.45M |
| Cost of revenue | -12.83%74.67M | 319.38%85.66M | ||||||||
| Gross profit | -58.23%14.7M | 44.29%35.18M | ||||||||
| Operating expense | -31.95%11.1M | -42.82%18.9M | 99.53%20.6M | -29.13%25.82M | -25.99%19.34M | -47.05%16.32M | 159.80%33.05M | -17.02%10.32M | 301.60%36.43M | 145.57%26.13M |
| Selling and administrative expenses | -23.82%10.95M | ---- | ---- | ---- | ---- | -19.91%14.38M | ---- | ---- | ---- | ---- |
| -General and administrative expense | -23.82%10.95M | ---- | ---- | ---- | ---- | -19.91%14.38M | ---- | ---- | ---- | ---- |
| Other operating expenses | -89.22%262.25K | -38.59%20.73M | 49.79%20.79M | -30.17%26.32M | -26.15%19.63M | -81.12%2.43M | 80.00%33.76M | 10.35%13.88M | 311.62%37.69M | 146.66%26.58M |
| Total other operating income | -77.11%113.64K | 157.06%1.84M | -94.55%194K | -60.37%499K | -35.81%285K | 1,831.82%496.48K | -88.16%715K | 2,496.35%3.56M | 1,381.18%1.26M | 233.83%444K |
| Operating profit | -80.95%3.59M | -84.87%1.67M | -52.65%1.73M | -99.14%73K | -85.83%753K | 393.24%18.86M | 220,700.00%11.03M | 341.74%3.66M | 12,570.15%8.49M | 654.80%5.32M |
| Net non-operating interest income (expenses) | 46.73%-7.3M | 110.51%727K | 4.90%-3.88M | 57.85%-1.82M | 17.90%-2.6M | 3.01%-13.71M | -99.02%-6.92M | 2.51%-4.08M | -19.20%-4.31M | 6.83%-3.17M |
| Non-operating interest income | -45.57%270.28K | --727K | ---- | ---- | ---- | -8.38%496.59K | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -46.69%7.57M | ---- | -4.90%3.88M | -57.85%1.82M | -17.90%2.6M | -3.21%14.2M | 99.02%6.92M | -2.51%4.08M | 19.20%4.31M | -6.83%3.17M |
| Net investment income | -99.90%4K | 4.02M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 0 | 0 | 0 | 154.05%68.01K | 0 | 125.00%1K | 155.00%66K | 0.00%1K |
| Special income (charges) | -78.47%66K | -94.47%306.52K | ||||||||
| Less:Impairment of capital assets | --0 | ---- | ---- | ---- | ---- | 99.88%-6.52K | ---- | ---- | ---- | ---- |
| Less:Other special charges | 78.00%-66K | ---- | ---- | ---- | ---- | -144.81%-300K | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | 58.68%300.98K | -32.84%189.68K | ||||||||
| Income before tax | -134.25%-3.34M | -41.70%2.4M | -416.63%-2.14M | -141.05%-1.74M | -185.95%-1.85M | 165.57%9.75M | 218.04%4.11M | 87.64%-415K | 215.79%4.25M | 149.33%2.15M |
| Income tax | -129.30%-1.42M | -142.32%-1.47M | 48.79%-211K | -77.64%125K | -91.00%133K | 271.48%4.84M | 756.93%3.46M | -157.54%-412K | 535.23%559K | 1,523.08%1.48M |
| Net income | 171.24%9.11M | 179.74%12.71M | -449.78%-2.55M | -84.44%509K | -546.86%-1.56M | 54.29%-12.79M | -20.99%-15.94M | 89.30%-464K | 171.30%3.27M | 105.97%350K |
| Net income continuous operations | -139.14%-1.92M | 495.83%3.86M | -64,333.33%-1.93M | -150.66%-1.87M | -394.64%-1.98M | 130.34%4.9M | 116.68%648K | 99.93%-3K | 198.19%3.69M | 115.11%672K |
| Net income discontinuous operations | 162.34%11.03M | 153.35%8.85M | -34.06%-618K | 672.77%2.38M | 229.50%417K | -49.82%-17.69M | -78.53%-16.59M | -75.29%-461K | 50.24%-415K | 77.29%-322K |
| Noncontrolling interests | 288.48%3.83M | 206.37%2.59M | 311.64%601K | 793.33%402K | 13.27%239K | -19.62%-2.03M | -101.91%-2.44M | -7.01%146K | 111.75%45K | 179.03%211K |
| Net income attributable to the company | 149.08%5.28M | 174.94%10.12M | -416.72%-3.15M | -96.68%107K | -1,397.12%-1.8M | 59.07%-10.75M | -12.85%-13.51M | 86.42%-610K | 176.70%3.23M | 102.48%139K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 149.08%5.28M | 174.94%10.12M | -416.72%-3.15M | -96.68%107K | -1,397.12%-1.8M | 59.07%-10.75M | -12.85%-13.51M | 86.42%-610K | 176.70%3.23M | 102.48%139K |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 149.01%0.0469 | 174.96%0.0901 | -418.52%-0.028 | -96.86%0.0009 | -1,433.33%-0.016 | 59.05%-0.0957 | -12.86%-0.1202 | 85.56%-0.0054 | 176.74%0.0287 | 102.41%0.0012 |
| Diluted earnings per share | 149.01%0.0469 | 174.96%0.0901 | -418.52%-0.028 | -96.86%0.0009 | -1,433.33%-0.016 | 59.05%-0.0957 | -12.86%-0.1202 | 85.56%-0.0054 | 176.74%0.0287 | 102.41%0.0012 |
| Dividend per share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.